decreased glutathione parkinson's disease Enhanced accumulation of reduced by Scopoletin improves survivability of dopaminergic neurons in model Chemically induced models of Parkinson's

Theoretical synergy: three pathways working together Triple-pathway hypothesis: Why it might work: Non-overlapping receptor pathways Complementary not redundant Multiple appetite suppression mechanisms Enhanced metabolic effects Potential for greater weight loss than either alone Comparison to proven combinations: CagriSema (semaglutide + cagrilintide): 15-25% proven Tirzepatide alone: 15-22% proven Theoretical tirzepatide + cagrilintide: 20-30% unproven The critical problem: no clinical data What we DON'T know: Is the combination safe

CRC Press, pp 4559 Kol, J., & Machkov, I

Wang QY, Zeng YT, Zeng XL, Wang X, Wang YC, Dai CP, et al

Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells